Brief: JCR Pharmaceuticals Plans To Start Clinical Trial In Japan In First Half Of FY24
02/07/2024 12:38
July 2 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T :
* MEDIPAL AND JCR ANNOUNCE COMPLETION OF CLINICAL TRIAL
NOTIFICATION PROCESS IN JAPAN FOR PHASE I/II STUDY OF JR-446 FOR
MUCOPOLYSACCHARIDOSIS TYPE IIIB
* JCR PHARMACEUTICALS CO LTD - PLAN TO START CLINICAL TRIAL
IN
JAPAN IN FIRST HALF OF FY2024 (APRIL TO SEPTEMBER)
Source text for Eikon: ID:nBw12lqq4a
Further company coverage: 4552.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipal Holdings
See all newsBrief: Medipal Holdings Corp Says It Will Buy Back Up To 2% Of Own Shares Worth 10 Billion Yen
Table: Medipal Holdings -2026/27 group forecast
Brief: Medipal Holdings Announces It Has Received Demand For EGM From Shareholder Silchester International Investors
Brief: Silchester International Raises Stake In Medipal Holdings Corp To 11.96% From 11.73%, Filing Shows
Brief: Silchester To Make Proposals Regarding Higher Dividend, Share Buyback, Share Retirement, Composition Of Board Of Directors If No Improvement In Dialogue With Medipal Holdings, Filing Shows